NCT02308124View on ClinicalTrials.gov

Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study

PHASE4CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Orthostatic; Hypotension, Neurogenic
Interventions
DRUG

Midodrine

DRUG

Pyridostigmine Bromide

DRUG

Midodrine + pyridostigmine

Trial Locations (1)

Unknown

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT02308124 - Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study | Biotech Hunter | Biotech Hunter